Envisagenics
Envisagenics is a biotechnology company founded by Maria Luisa Pineda and Martin Akerman in 2014 and headquartered in New York City, New York using artificial intelligence and RNA sequencing to develop therapeutics to treat genetic diseases.
9
Funding Rounds
$26.8m
Money raised
Overview
Envisagenics is a biotechnology company founded by Maria Luisa Pineda and Martin Akerman in 2014 and headquartered in New York City, New York using artificial intelligence and RNA sequencing to develop therapeutics to treat genetic diseases.
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma*** Lu*** Pi**** | - | - | |
| Ma**** Ak***** | - | - | - |
Industries
Envisagenics is active in the following industries: